$301.90
-2.46 (-0.81%)
At Close: Jul 20, 2026
Should You Continue to Hold Bio-Rad Stock in Your Portfolio?
11:11am, Tuesday, 01'st Oct 2024
BIO strategically expands its ddPCR platform while eyeing global expansion and benefiting from its clinical diagnostics arm.
BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING
07:00am, Tuesday, 24'th Sep 2024
MINNEAPOLIS , Sept. 24, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its portfolio of solutions advancing neuroscience research at the upcoming annual me
BIO-key, International (BKYI) Expands Deployment with Province of British Columbia, Adds 10,000 Biometric Users for Sign-on and Physical Access Control.
BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORT
07:00am, Wednesday, 18'th Sep 2024
MINNEAPOLIS , Sept. 18, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today issued its 2024 Corporate Sustainability Report (CSR), detailing the continued progress advancing its Environme
BIO-key International Enters into $1.9 Million Warrant Inducement
01:18pm, Thursday, 12'th Sep 2024
HOLMDEL, N.J., Sept. 12, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featurin
Leading Government Defense Ministry Awards BIO-key $500K In Follow-On Orders for Biometric User Authentication
08:27am, Tuesday, 10'th Sep 2024
HOLMDEL, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featurin
NEW YORK , Sept. 6, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of
BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
07:00am, Monday, 26'th Aug 2024
MINNEAPOLIS , Aug. 26, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer will present at the following investor conf
Bio-Rad's Management to Participate in Fireside Chat During Wells Fargo's 2024 Healthcare Conference
04:30pm, Thursday, 22'nd Aug 2024
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company's Chie
Identity and Access Management Software Provider BIO-key to Participate at H.C. Wainwright Investment Conf.
01:10pm, Thursday, 22'nd Aug 2024
HOLMDEL, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) software featuring
Reasons to Retain Bio-Rad (BIO) Stock in Your Portfolio Now
09:16am, Thursday, 22'nd Aug 2024
Bio-Rad's (BIO) robust digital PCR business and Clinical Diagnostics segments raise optimism. However, macro issues raise concerns.
$BKYI BIO-key's PortalGuard Identity Access Management Solution & Identity-Bound Biometrics Are Now Available on the Amazon Web Services (AWS) Marketplace
BIO-key Reports Reduced Net Loss and Cash Used in Operations on Lower Q2'24 Revenues; Hosts Investor Call Thu. Aug. 15th at 10am ET
04:30pm, Wednesday, 14'th Aug 2024
HOLMDEL, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) -- BIO-key ® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featurin
Bio-Rad (BIO) Faces Low BioPharma Demand, Competitive Pressure
12:16pm, Monday, 12'th Aug 2024
Bio-Rad (BIO) is experiencing weaker sales in Asia as China is currently entangled in a challenging research funding environment, and Japan, too, is facing constrained funding issues.
Identity and Access Management Solutions Provider BIO-key Hosts Q2 Investor Call Thursday, August 15th at 10am ET
10:35am, Monday, 12'th Aug 2024
HOLMDEL, N.J., Aug. 12, 2024 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management and Identity-Bound Biometric solutions, will host
Sign In
Buy BIO